Faran Ahmad

Dr. Faran Ahmad

Creighton University Medical Center, Omaha, Nebraska, USA
orcid
Assistant Professor of Medicine, Division of ID & PCCM.

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
Faran AhmadFaran Ahmad
Faran Ahmad
AAArslan Ahmed
Arslan Ahmed
SRSanu S. Rajendraprasad
Sanu S. Rajendraprasad
ALAustin Loranger
Austin Loranger
SGSonia Gupta
Sonia Gupta
DMDouglas Moore
Douglas Moore
Multisystem inflammatory syndrome in adults (MIS-A) came to attention back in June 2020, when the United States Center for Disease Control and Prevention (CDC) received initial reports regarding patients who had presented delayed and multisystem involvement of the disease, with clinical course resembling multisystem inflammatory syndrome in children (MIS-C). This study introduces a case of MIS-A, where the patient presented 3 weeks after initial COVID-19 exposure. His clinical course was consistent with the working definition of MIS-A as specified by the CDC. Aggressive supportive care in the intensive care unit, utilization of advanced heart failure devices, and immunomodulatory therapeutics (high-dose steroids, anakinra, intravenous immunoglobulin) led to clinical recovery. Management of MIS-A is a topic of ongoing research and needs more studies to elaborate on treatment modalities and clinical predictors.

9 August 2021 in Cureus
Verified
Journal Article
Open access
Faran AhmadFaran Ahmad
Faran Ahmad
MBMargaret Brubaker
Margaret Brubaker
SRSanu S. Rajendraprasad
Sanu S. Rajendraprasad
BHBrian Hoeynck
Brian Hoeynck
BCBrent L. Clyde
Brent L. Clyde
MVManasa Velagapudi
Manasa Velagapudi
Gram-negative bacterial infections of the central nervous system (CNS) have worse clinical outcomes. The most common bacteria include Escherichia Coli, Citrobacter species, Enterobacter species, Serratia species, and Pseudomonas aeruginosa. There are multiple risk factors for CNS infection after shunt insertion, including younger age, obstructive hydrocephalus, shunt revision surgery, and trauma. The clinical presentation of a ventriculoperitoneal (VP) shunt infection includes the signs and symptoms of meningitis to fever with abdominal pain and peritonitis. Apart from cerebrospinal fluid (CSF) analysis, microbiological cultures and radiological studies are key diagnostic tools. Initial empirical intravenous antimicrobial therapy is preferably broad spectrum with appropriate coverage for resistant Gram-negative pathogens and the duration of treatment depends upon pathogenesis, host factors, and clinical response to the therapy. Considering the importance of this disease and associated clinical outcomes, in this review article, we have summarized the epidemiology, clinical features, management, and prevention of Gram-negative VP shunt infections in adults.

1 April 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
SPShiv A. Patel
Shiv A. Patel
ARAjay K. Rajan
Ajay K. Rajan
AAAhad Azeem
Ahad Azeem
INIrene L. Newquist
Irene L. Newquist
LRLesley L. Royal
Lesley L. Royal
MBMarvin J. Bittner
Marvin J. Bittner

21 December 2022 in Cureus
Verified
Journal Article
Open access
RIRaul D Isern
Raul D Isern
STStephen Toth
Stephen Toth
MGMikhail Goldfarb
Mikhail Goldfarb
Faran AhmadFaran Ahmad
Faran Ahmad
Brain abscess is a life-threatening illness that occurs when an intracerebral infection leads to cerebritis and subsequent pus formation within a well-vascularized capsule. While streptococci (aerobic, anaerobic, and microaerophilic) are the most common bacteria isolated, its presentation as multifocal brain abscesses is rarely described. In this report, we describe a 43-year-old male patient who presented to the emergency department due to progressive lethargy and low-grade fever of seven days worsening. Upon further evaluation, the patient was found to have multiple brain abscesses secondary to Streptococcus intermedius, confirmed by the culture of stereotactic aspiration of brain collection. This case underlines the importance of considering Streptococcus intermedius as a cause of multifocal brain abscesses.

26 January 2023 in Cureus
Verified
Journal Article
Open access
PDF file
Faran AhmadFaran Ahmad
Faran Ahmad
MMMatthew Merwin
Matthew Merwin
BKBryan Krajicek
Bryan Krajicek
AJAbbis H. Jaffri
Abbis H. Jaffri
Introduction: Researchers are increasingly interested in appraising the impact of their research work, which eventually drives public perception. The overall impact of a study can only be gauged if we consider both traditional and non-traditional dissemination patterns. Hence, we preferred to study the association between the non-traditional reader engagement metrics and traditional dissemination metrics in relation to coronavirus disease 2019 (COVID-19)-related research published in five high-impact peer-reviewed medical journals. Method: This observational study was conducted using data sourced from Altmetric, including the Altmetric attention score (AAS), an aggregate score of an article’s dissemination. New England Journal of Medicine (NEJM), Lancet Infectious Diseases, Clinical Infectious Diseases (CID), Chest Journal (CHEST), and Journal of the American Medical Association (JAMA) were included in the study based on the prevalence of COVID-19-related original research published in each of them. The number of citations was framed as the reference for traditional metrics. To avoid artificial variance, data were collected on the same day, November 13, 2022. Correlational analyses were performed using the Pearson correlation coefficient using Minitab 17 (Minitab Inc., State College, PA). The relationship between the variables was considered very weak if r0.7. Results: We found a very weak correlation between citations and AAS for Clinical Infectious Diseases, Lancet Infectious Diseases, and CHEST, whereas the correlation was moderate for NEJM and JAMA. The correlation between citations and Twitter mentions was very weak for Clinical Infectious Disease, Lancet Infectious Disease, and CHEST, but it improved for NEJM and JAMA. There was a very weak correlation between citations and news mentions for Clinical Infectious Diseases, Lancet Infectious Diseases, and CHEST. Conclusion: Our study highlights that the traditional indicator, i.e., citation has a very weak to moderate correlation with the AAS and it doesn’t capture the entire influence of a research publication. Also, the current method of determining a journal's impact factor doesn’t take this disparity into consideration. Hence, there needs to have a more inclusive strategy to define the impact of scientific research on the general population in real-time.

28 November 2023 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
TJTheresa Jizba
Theresa Jizba
Faran AhmadFaran Ahmad
Faran Ahmad
RWRyan W. Walters
Ryan W. Walters
PFPamela A. Foral
Pamela A. Foral
Christopher J. DestacheChristopher J. Destache
Christopher J. Destache
MVManasa Velagapudi
Manasa Velagapudi
Metronidazole treats obligate anaerobic bacterial and protozoal infections, with an elimination half-life of around 8 hours. The long elimination half-life, the favorable ratio of steady-state serum levels to minimum inhibitory concentration, and the presence of active metabolites have led to the consideration of metronidazole use at 12-hour dosage intervals. This systematic review aimed to compare the clinical outcomes of twice-daily and thrice-daily metronidazole dosing. Using the PRISMA checklist, we searched five databases to systematically identify all relevant studies published up to June 16, 2023. The final analysis included two published retrospective cohort studies of hospitalized adult patients: a single site study (n = 200) and a multisite study (n = 85) of "good" quality, as measured by the Newcastle-Ottawa scale. The reported baseline characteristics of the 8-hour and 12-hour dosing groups were comparable, and neither study identified significant differences in primary and secondary clinical outcomes. Metaanalysis of the need to escalate antibiotic therapy also showed no statistically significant differences using the Mantel-Haenszel fixed-effect method (95% confidence interval: 47.6% lower to 6.4 times higher risk, P = 0.34) and inverse-variance method (risk ratio: 1.87; 95% confidence interval: 0.52-6.65, P = 0.34). This review suggests that dosing metronidazole every 12 hours is as effective as every-8-hour dosing for hospitalized patients with anaerobic infections. These encouraging findings would benefit from validation by a multicenter randomized controlled trial since there would be many benefits to a 12-hour dosing interval while achieving similar clinical outcomes with traditional dosing. The studies in this systematic review excluded patients with Clostridioides difficile and central nervous system and amebiasis infections, so the findings do not apply to these infection types.